Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00817297Not ApplicableCompleted

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

Role: lead

NCT02867228Not ApplicableTerminated

Noninvasive Estimation of Work of Breathing

Role: lead

NCT01800448Completed

Variability Analysis During Weaning and Extubation in Critically Ill Patients

Role: collaborator

NCT00817804Not ApplicableCompleted

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

Role: lead

All 4 trials loaded